Initiation of Neuronal Damage by Complex I Deficiency and Oxidative Stress in Parkinson's Disease

Neurochemical Research

Volumn 29, Issue 3, 2004, Pages 569-577

  Tretter, Laszlo ^a   Sipos, Ildiko ^b   Adam Vizi, Vera ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Complex I deficiency; Dopaminergic neurons; Oxidative stress; Parkinson's disease; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYDROGEN PEROXIDE; OXOGLUTARATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

BIOENERGY; BRAIN MITOCHONDRION; DOPAMINERGIC NERVE CELL; ENZYME DEFICIENCY; HUMAN; MITOCHONDRIAL RESPIRATION; NIGRONEOSTRIATAL SYSTEM; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ELECTRON TRANSPORT COMPLEX I; ENERGY METABOLISM; HUMANS; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES;

EID: 1542318096     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000014827.94562.4b     Document Type: Review

References (104)

1. Mizuno, Y., Hattori, N., and Matsumine, H. 1998. Neurochemical and neurogenetic correlates of Parkinson's disease. J. Neurochem. 71:893-902.
2. Mizuno, Y., Yoshino, H., Ikebe, S., Hattori, N., Kobayashi, T., Shimoda-Matsubayashi, S., Matsumine, H., and Kondo, T. 1998. Mitochondrial dysfunction in Parkinson's disease. Ann. Neurol. 44:S99-S109.
3. Orth, M. and Schapira, A. H. 2002. Mitochondrial involvement in Parkinson's disease. Neurochem. Int. 40:533-541.
4. Walker, J. E. 1992. The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains. Q. Rev. Biophys. 25:253-324.
5. Kosel, S., Grasbon-Frodl, E. M., Mautsch, U., Egensperger, R., von Eitzen, U., Frishman, D., Hofmann, S., Gerbitz, K. D., Mehraein, P., and Graeber, M. B. 1998. Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics 1:197-204.
6. Petruzzella, V. and Papa, S. 2002. Mutations in human nuclear genes encoding for subunits of mitochondrial respiratory complex I: The NDUFS4 gene. Gene 286:149-154.
7. Nicklas, W. J., Vyas, I., and Heikkila, R. E. 1985. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36:2503-2508.
8. Ramsay, R. R., Salach, J. I., Dadgar, J., and Singer, T. P. 1986. Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism. Biochem. Biophys. Res. Commun. 135:269-275.
9. Tipton, K. F. and Singer, T. P. 1993. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61:1191-1206.
10. Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. 1983. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980.
11. Langston, J. W., Forno, L. S., Rebert, C. S., and Irwin, I. 1984. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 292:390-394.
12. Ricaurte, G. A., Langston, J. W., Delanney, L. E., Irwin, I., Peroutka, S. J., and Forno, L. S. 1986. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment. Brain Res. 376:117-124.
13. Kaakkola, S. and Teravainen, H. 1990. Animal models of parkinsonism. Pharmacol. Toxicol. 67:95-100.
14. Parker, W. D. Jr., Boyson, S. J., and Parks, J. K. 1989. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26:719-723.
15. Schapira, A. H., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., and Marsden, C. D. 1989. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1:1269.
16. Schapira, A. H., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., and Marsden, C. D. 1990. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:823-827.
17. Mann, V. M., Cooper, J. M., Krige, D., Daniel, S. E., Schapira, A. H., and Marsden, C. D. 1992. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115:333-342.
18. Cardellach, F., Marti, M. J., Fernandez-Sola, J., Marin, C., Hoek, J. B., Tolosa, E., and Urbano-Marquez, A. 1993. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology 43:2258-2262.
19. Sheehan, J. P., Swerdlow, R. H., Parker, W. D., Miller, S. W., Davis, R. E., and Tuttle, J. B. 1997. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J. Neurochem. 68:1221-1233.
20. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:1301-1306.
21. Swerdlow, R. H., Parks, J. K., Davis, J. N., Cassarino, D. S., Trimmer, P. A., Currie, L. J., Dougherty, J., Bridges, W. S., Bennett, J. P. Jr., Wooten, G. F., and Parker, W. D. 1998. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann. Neurol. 44:873-881.
22. Jenner, P. 2001. Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci. 24:245-247.
23. Cassarino, D. S. and Bennett, J. P. Jr. 1999. An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Brain Res. Rev. 29:1-25.
24. Schapira, A. H. 1999. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim. Biophys. Acta 1410:159-170.
25. Giasson, B. I., Ischiropoulos, H., Lee, V. M., and Trojanowski, J. Q. 2002. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's disease. Free Radic. Biol. Med. 32:1264-1275.
26. Schon, E. A. and Manfredi, G. 2003. Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest 111:303-312.
27. Bindoff, L. A., Birch-Machin, M. A., Cartlidge, N. E., Parker, W. D. Jr., and Turnbull, D. M. 1991. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 104:203-208.
28. Barroso, N., Campos, Y., Huertas, R., Esteban, J., Molina, J. A., Alonso, A., Gutierrez-Rivas, E., and Arenas, J. 1993. Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease. Clin. Chem. 39:667-669.
29. Mizuno, Y., Matuda, S., Yoshino, H., Mori, H., Hattori, N., and Ikebe, S. 1994. An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol. 35:204-210.
30. Noll, T., Koop, A., and Piper, H. M. 1992. Mitochondrial ATP-synthase activity in cardiomyocytes after aerobic-anaerobic metabolic transition. Am. J. Physiol 262:C1297-C1303.
31. Singer, T. P. and Ramsay, R. R. 1990. Mechanism of the neurotoxicity of MPTP: An update. FEBS Lett. 274:1-8.
32. Davey, G. P. and Clark, J. B. 1996. Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J. Neurochem. 66:1617-1624.
33. Davey, G. P., Peuchen, S., and Clark, J. B. 1998. Energy thresholds in brain mitochondria: Potential involvement in neurodegeneration. J. Biol. Chem. 273:12753-12757.
34. Chinopoulos, C. and Adam-Vizi, V. 2001. Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: Relevance to Parkinson's disease. J. Neurochem. 76:302-306.
35. Scott, I. D. and Nicholls, D. G. 1980. Energy transduction in intact synaptosomes: Influence of plasma-membrane depolarization on the respiration and membrane potential of internal mitochondria determined in situ. Biochem. J. 186:21-33.
36. Budd, S. L. and Nicholls, D. G. 1996. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurochem. 67:2282-2291.
37. Barrientos, A. and Moraes, C. T. 1999. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 274:16188-16197.
38. Beal, M. F. 1995. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:357-366.
39. Zhang, Y., Marcillat, O., Giulivi, C., Ernster, L., and Davies, K. J. 1990. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265:16330-16336.
40. Schapira, A. H. 1994. Mitochondrial dysfunction in neurodegenerative disorders and aging. Pages 227-244, in Schapira, A. H. and DiMauro, S. (eds.), Mitochondrial Disorders in Neurology, Butterworth-Heinemann, Oxford.
41. Jakel, R. J. and Maragos, W. F. 2000. Neuronal cell death in Huntington's disease: A potential role for dopamine. Trends Neurosci. 23:239-245.
42. Halliwell, B. and Gutteridge, J. M. C. 1999. Antioxydant defence enzymes: The gluthatione peroxidase family. Pages 140-146, in Halliwell, B. and Gutteridge, J. M. C. (eds.), Free Radicals in Biology and Medicine, Oxford University Press, Oxford.
43. Satrustegui, J. and Richter, C. 1984. The role of hydroperoxides as calcium release agents in rat brain mitochondria. Arch. Biochem. Biophys. 233:736-740.
44. Desagher, S., Glowinski, J., and Premont, J. 1996. Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 16:2553-2562.
45. Dringen, R., Kussmaul, L., Gutterer, J. M., Hirrlinger, J., and Hamprecht, B. 1999. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J. Neurochem. 72:2523-2530.
46. 2 production in pigeon heart mitochondria. FEBS Lett. 18:261-264.
47. Boveris, A., Oshino, N., and Chance, B. 1972. The cellular production of hydrogen peroxide. Biochem. J. 128:617-630.
48. Boveris, A. and Chance, B. 1973. The mitochondrial generation of hydrogen peroxide: General properties and effect of hyperbaric oxygen. Biochem. J. 134:707-716.
49. Perry, T. L., Godin, D. V., and Hansen, S. 1982. Parkinson's disease: A disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:305-310.
50. Perry, T. L. and Yong, V. W. 1986. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67:269-274.
51. Jenner, P. 1992. What process causes nigral cell death in Parkinson's disease? Neurol. Clin. 10:387-403.
52. Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., and Marsden, C. D. 1989. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J. Neurochem. 53:692-697.
53. Damier, P., Hirsch, E. C., Zhang, P., Agid, Y., and Javoy-Agid, F. 1993. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52:1-6.
54. Chiueh, C. C., Huang, S. J., and Murphy, D. L. 1992. Enhanced hydroxyl radical generation by 2′-methyl analog of MPTP: Suppression by clorgyline and deprenyl. Synapse 11:346-348.
55. Adams, J. D. Jr., Klaidman, L. K., and Leung, A. C. 1993. MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes. Free Radic. Biol. Med. 15:181-186.
56. Ali, S. F., David, S. N., Newport, G. D., Cadet, J. L., and Slikker, W. Jr. 1994. MPTP-induced oxidative stress and neurotoxicity are age-dependent: Evidence from measures of reactive oxygen species and striatal dopamine levels. Synapse 18:27-34.
57. Cassarino, D. S., Fall, C. P., Swerdlow, R. H., Smith, T. S., Halvorsen, E. M., Miller, S. W., Parks, J. P., Parker, W. D. Jr., and Bennett, J. P. Jr. 1997. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta 1362:77-86.
58. Thiffault, C., Aumont, N., Quirion, R., and Poirier, J. 1995. Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J. Neurochem. 65:2725-2733.
59. Swerdlow, R. H., Parks, J. K., Miller, S. W., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P. Jr., Davis, R. E., and Parker, W. D. Jr. 1996. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40:663-671.
60. Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., and Marsden, C. D. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:381-389.
61. Jenner, P., Dexter, D. T., Sian, J., Schapira, A. H., and Marsden, C. D. 1992. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease: The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. 32(Suppl):S82-S87.
62. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., and Mizuno, Y. 1996. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93:2696-2701.
63. Cadenas, E., Boveris, A., Ragan, C. I., and Stoppani, A. O. 1977. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys. 180:248-257.
64. Cadenas, E. and Boveris, A. 1980. Enhancement of hydrogen peroxide formation by protophores and ionophores in antimycin-supplemented mitochondria. Biochem. J. 188:31-37.
65. Turrens, J. F. and Boveris, A. 1980. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191:421-427.
66. Votyakova, T. V. and Reynolds, I. J. 2001. DeltaPsi(m)-dependent and -independent production of reactive oxygen species by rat brain mitochondria. J. Neurochem. 79:266-277.
67. Liu, Y., Fiskum, G., and Schubert, D. 2002. Generation of reactive oxygen species by the mitochondrial electron transport chain. J. Neurochem. 80:780-787.
68. Sipos, I., Tretter, L., and Adam-Vizi, V. 2003. Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals. J. Neurochem. 84:112-118.
69. Davies, K. J. 1987. Protein damage and degradation by oxygen radicals: I. general aspects. J. Biol. Chem. 262:9895-9901.
70. Halliwell, B. and Gutteridge, J. M. 1984. Free radicals, lipid peroxidation, and cell damage. Lancet 2:1095.
71. Breen, A. P. and Murphy, J. A. 1995. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 18:1033-1077.
72. Bates, T. E., Heales, S. J., Davies, S. E., Boakye, P., and Clark, J. B. 1994. Effects of 1-methyl-4-phenylpyridinium on isolated rat brain mitochondria: Evidence for a primary involvement of energy depletion. J. Neurochem. 63:640-648.
73. Bolanos, J. P., Heales, S. J., Land, J. M., and Clark, J. B. 1995. Effect of peroxynitrite on the mitochondrial respiratory chain: Differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64:1965-1972.
74. Brookes, P. S., Land, J. M., Clark, J. B., and Heales, S. J. 1998. Peroxynitrite causes proton leak in brain mitochondria. Biochem. Soc. Trans. 26:S332
75. Bolanos, J. P., Heales, S. J., Peuchen, S., Barker, J. E., Land, J. M., and Clark, J. B. 1996. Nitric oxide-mediated mitochondrial damage: A potential neuroprotective role for glutathione. Free Radic. Biol. Med. 21:995-1001.
76. Heales, S. J., Bolanos, J. P., Stewart, V. C., Brookes, P. S., Land, J. M., and Clark, J. B. 1999. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta 1410:215-228.
77. Friberg, H. and Wieloch, T. 2002. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84:241-250.
78. Chinopoulos, C., Tretter, L., and Adam-Vizi, V. 1999. Depolarization of in situ mitochondria due to hydrogen peroxide-induced oxidative stress in nerve terminals: Inhibition of alpha-ketoglutarate dehydrogenase. J. Neurochem. 73:220-228.
79. 2+. J. Neurochem. 64:2552-2558.
80. Tretter, L., Chinopoulos, C., and Adam-Vizi, V. 1997. Enhanced depolarization-evoked calcium signal and reduced [ATP]/[ADP] ratio are unrelated events induced by oxidative stress in synaptosomes. J. Neurochem. 69:2529-2537.
81. Hyslop, P. A., Hinshaw, D. B., Halsey, W. A. Jr., Schraufstatter, I. U., Sauerheber, R. D., Spragg, R. G., Jackson, J. H., and Cochrane, C. G. 1988. Mechanisms of oxidant-mediated cell injury: The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J. Biol. Chem. 263:1665-1675.
82. Janero, D. R., Hreniuk, D., and Sharif, H. M. 1993. Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): Nonperoxidative purine and pyrimidine nucleotide depletion. J. Cell Physiol. 155:494-504.
83. Tretter, L. and Adam-Vizi, V. 2000. Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci. 20:8972-8979.
84. Gardner, P. R., Raineri, I., Epstein, L. B., and White, C. W. 1995. Superoxide radical and iron modulate aconitase activity in mammalian cells. J. Biol. Chem. 270:13399-13405.
85. Patel, M., Day, B. J., Crapo, J. D., Fridovich, I., and McNamara, J. O. 1996. Requirement for superoxide in excitotoxic cell death. Neuron 16:345-355.
86. Hausladen, A. and Fridovich, I. 1996. Measuring nitrix oxide and superoxide: Rate constants for aconitase activity. Methods Enzymol. 269:37-41.
87. Andersson, U., Leighton, B., Young, M. E., Blomstrand, E., and Newsholme, E. A. 1998. Inactivation of aconitase and oxoglutarate dehydrogenase in skeletal muscle in vitro by superoxide anions and/or nitric oxide. Biochem. Biophys. Res. Commun. 249:512-516.
88. Liang, L. P., Ho, Y. S., and Patel, M. 2000. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 101:563-570.
89. Li, Q. Y., Pedersen, C., Day, B. J., and Patel, M. 2001. Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation. J. Neurochem. 78:746-755.
90. Vasquez-Vivar, J., Kalyanaraman, B., and Kennedy, M. C. 2000. Mitochondrial aconitase is a source of hydroxyl radical: An electron spin resonance investigation. J. Biol. Chem. 275:14064-14069.
91. Humphries, K. M. and Szweda, L. I. 1998. Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: Reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37:15835-15841.
92. Park, L. C., Zhang, H., Sheu, K. F., Calingasan, N. Y., Kristal, B. S., Lindsay, J. G., and Gibson, G. E. 1999. Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J. Neurochem. 72:1948-1958.
93. Gibson, G. E., Park, L. C., Sheu, K. F., Blass, J. P., and Calingasan, N. Y. 2000. The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem. Int. 36:97-112.
94. Mizuno, Y., Saitoh, T., and Sone, N. 1987. Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion. Biochem. Biophys. Res. Commun. 143:971-976.
95. Chinopoulos, C., Tretter, L., Rozsa, A., and Adam-Vizi, V. 2000. Exacerbated responses to oxidative stress by an Na(+) load in isolated nerve terminals: The role of ATP depletion and rise of [Ca(2+)](i). J. Neurosci. 20:2094-2103.
96. + channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. J. Neurosci. 16:5004-5013.
97. Scanlon, J. M. and Reynolds, I. J. 1998. Effects of oxidants and glutamate receptor activation on mitochondrial membrane potential in rat forebrain neurons. J. Neurochem. 71:2392-2400.
98. Marey-Semper, I., Gelman, M., and Levi-Strauss, M. 1995. A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci. 15:5912-5918.
99. Lafon-Cazal, M., Pietri, S., Culcasi, M., and Bockaert, J. 1993. NMDA-dependent superoxide production and neurotoxicity. Nature 364:535-537.
100. Dugan, L. L., Sensi, S. L., Canzoniero, L. M., Handran, S. D., Rothman, S. M., Lin, T. S., Goldberg, M. P., and Choi, D. W. 1995. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15:6377-6388.
101. Reynolds, I. J. and Hastings, T. G. 1995. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15:3318-3327.
102. Graham, D. G., Tiffany, S. M., Bell, W. R. Jr., and Gutknecht, W. F. 1978. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:644-653.
103. Berman, S. B. and Hastings, T. G. 1999. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease. J. Neurochem. 73:1127-1137.
104. Cohen, G., Farooqui, R., and Kesler, N. 1997. Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl. Acad. Sci. USA 94:4890-4894.